Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Forecast for the Respiratory Syncytial Virus (RSV) Diagnostics Market Growth in 2025?
The market for diagnosing respiratory syncytial virus (RSV) has seen a swift increase in size over the past few years. It’s projected to expand from $1.01 billion in 2024 to $1.12 billion in 2025, boasting a compound annual growth rate (CAGR) of 11.0%. This robust growth in the past can be credited to the surging use of point-of-care diagnostics, government-led efforts to enhance RSV diagnostics, an increasing number of respiratory illnesses in children, a rise in infections acquired in hospitals, and boosted demand for non-invasive techniques for diagnosis.
What Is the Forecast for the Respiratory Syncytial Virus (RSV) Diagnostics Market Size Through 2029?
In the upcoming years, the respiratory syncytial virus (RSV) diagnostics market is projected to witness a significant expansion. The market is anticipated to reach $1.68 billion by 2029 with a Compound Annual Growth Rate (CAGR) of 10.7%. The expansion during the forecasted period is associated with factors such as a rise in infections of respiratory syncytial virus (RSV), increased awareness around RSV diagnostics, enlargement of healthcare infrastructure, escalating global healthcare expenditure, and the growing elderly population. Noteworthy trends during the projected period include progressions in molecular diagnostic methodologies, technological enhancements in diagnostic tools, embracement of rapid diagnostic tests (RDTs), growth of diagnostic test collections by organizations, and advancements in the genetic and proteomic diagnostics.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21273&type=smp
What are the Key Market Players in Respiratory Syncytial Virus (RSV) Diagnostics Market and How They’re Evolving?
Major companies operating in the respiratory syncytial virus (RSV) diagnostics market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Merck KGaA, Becton, Dickinson, and Company, Quest Diagnostics Incorporated, Hologic Inc., BIOMÉRIEUX SA, QuidelOrtho Corporation, Bio-Rad Laboratories Inc., DiaSorin S.p.A., Acon Laboratories Inc., Cepheid Inc., Meridian Bioscience Inc., Seegene Inc., LumiraDx Ltd., Sekisui Diagnostics Ltd., Boditech Med Inc., Trinity Biotech plc, R-Biopharm AG, GeneTex Inc., Creative Diagnostics, Certest Biotec S.L., Clarity Diagnostics LLC, Genes 2Me LLP, Coris BioConcept S.A.
What Are the Primary Growth Drivers in the Respiratory Syncytial Virus (RSV) Diagnostics Market?
The increase in respiratory illnesses is projected to propel the expansion of the market for respiratory syncytial virus (RSV) diagnostics. Respiratory ailments, including disorders that affect the lungs and airways, limit oxygen exchange and breathing, and involve diseases such as chronic obstructive pulmonary disease (COPD), pneumonia, respiratory infections, and asthma. The growing rate of these ailments is attributed to factors like escalating air pollution, tobacco usage, climate alterations, urbanization, and the rising instances of infections and chronic conditions like asthma and COPD. RSV diagnostics are critical for detecting respiratory diseases, enabling precise and prompt identification of RSV infections and allowing for efficient treatment, control, and prevention of severe complications, particularly in susceptible groups. For example, the Australian Institute of Health and Welfare reported in November 2024 that approximately 2.8 million people (11% of the population) in Australia were diagnosed with asthma in 2022. Asthma represented 2.5% of the total disease load and 35% of the load from all respiratory illnesses in 2023. It resulted in 467 deaths in 2022, equating to 1.8 deaths per 100,000 individuals and accounting for 0.2% of all deaths. As a result, the increasing rate of respiratory illnesses is driving the growth of the RSV diagnostics market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=21273&type=smp
What Are the Leading Segments in the Global Respiratory Syncytial Virus (RSV) Diagnostics Industry?
The respiratory syncytial virus (RSV) diagnostics market covered in this report is segmented –
1) By Product Type: Kits And Assays, Instruments, Reagents, Other Product Types
2) By Technology: Molecular Diagnostics, Immunoassays, Rapid Antigen Detection Tests, Other Technologies
3) By Sample Type: Nasal Swabs, Throat Swabs, Bronchoalveolar Lavage
4) By End User: Hospitals, Diagnostic Laboratories, Home Care Settings, Other End Users
Subsegments:
1) By Kits And Assays: Rapid Antigen Detection Kits, PCR-based Assays, Serological Assays
2) By Instruments: PCR Analyzers, Immunoassay Analyzers
3) By Reagents: PCR Reagents, Antibody Reagents, Enzyme Reagents
4) By Other Product Types: Sample Collection Devices, Transport Media
What Are the Key Market Trends in the Respiratory Syncytial Virus (RSV) Diagnostics Industry?
Leading businesses in the respiratory syncytial virus (RSV) diagnostics market are stepping up their game by creating groundbreaking products like respiratory virus combination testing, which offers precise and efficient solutions to clients. This diagnostic technique allows for the concurrent detection of assorted respiratory viruses including influenza and respiratory syncytial virus (RSV), among others, using a single sample, thereby aiding in the diagnosis of viral infections. For instance, in January 2023, the U.S.-based clinical laboratory testing firm, Sonora Quest Laboratories, introduced a diagnostic test for COVID-19, RSC, and influenza. This multi-target analysis, enabled by a single patient’s sample, efficiently detects COVID-19, respiratory syncytial virus (RSV), and influenza. Combining these three tests into a single procedure simplifies the testing routine and minimizes the need for multiple samples. This expedited identification of all three infections aids medical professionals in making swifter therapeutic choices, with potential beneficial impact on patient recovery. Furthermore, this test could play a crucial role in curbing the proliferation of these viruses, thus decreasing the risk of contagion to others.
Access The Full Report Here:
What Is the Regional Outlook for the Respiratory Syncytial Virus (RSV) Diagnostics Market?
North America was the largest region in the respiratory syncytial virus (RSV) diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the respiratory syncytial virus (RSV) diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21273
This Report Delivers Insight On:
1. How big is the respiratory syncytial virus (rsv) diagnostics market, and how is it changing globally?
2. Who are the major companies in the respiratory syncytial virus (rsv) diagnostics market, and how are they performing?
3. What are the key opportunities and risks in the respiratory syncytial virus (rsv) diagnostics market right now?
4. Which products or customer segments are growing the most in the respiratory syncytial virus (rsv) diagnostics market?
5. What factors are helping or slowing down the growth of the respiratory syncytial virus (rsv) diagnostics market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model